Non-nucleoside structures retain full anti-HCMV potency of the dideoxy furanopyrimidine family

Antivir Chem Chemother. 2004 Nov;15(6):329-32. doi: 10.1177/095632020401500605.

Abstract

We have recently reported that 2',3'dideoxy analogues of our exquisitely potent anti-VZV furanopyrimidine deoxynucleosides are shifted to selective anti-HCMV agents. We now find that the fully deoxygenated 2',3',5'-trideoxy analogue is fully antivirally active. This is taken as proof that these agents act by a novel non-nucleoside mechanism of action.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / chemical synthesis*
  • Antiviral Agents / pharmacology
  • Cell Line
  • Cytomegalovirus / drug effects*
  • Dideoxynucleosides / chemistry
  • Dideoxynucleosides / pharmacology*
  • Furans / chemistry*
  • Humans
  • Pyrimidine Nucleosides / chemical synthesis*
  • Pyrimidine Nucleosides / pharmacology
  • Structure-Activity Relationship
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Dideoxynucleosides
  • Furans
  • Pyrimidine Nucleosides